Age-Related Considerations in Cardio-Oncology
Journal of Cardiovascular Pharmacology and Therapeutics · 2021-03 · 26 (2) · 103-113
DOI: 10.1177/1074248420968689 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, online erschienen am 30.10.2020. Verfasst von Elles M Screever und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Cardiotoxicity. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: National Institute of Health, national institutes of health.
Abstract (Originalsprache)
Cardio-Oncology has blossomed as a new field in cardiovascular medicine, in large part due to new therapies, which may have cardiovascular sequelae. Despite this, anthracyclines still serve as cornerstone therapy for most pediatric cancers, several solid tumors and hematological malignancies. Cardiotoxicity is the main limiting concern with anthracyclines, and this is particularly an issue in patients in extremes of age (both young and old patients). Pediatric hearts are susceptible for cardiotoxicity, while in older patients, concomitant risk factors may contribute to lower threshold for cardiotoxic effects. With increasing patient survival, a significant increase in elderly cancer patients and long-term cardiotoxicity effects of anthracyclines, a better mechanistic understanding of age-dependent processes—that define cardiotoxicity—is needed. This review sheds light on how age affects underlying molecular pathways of anthracycline-associated cardiotoxicity and aims to provide preventive strategies that can be used in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
ORCID-Profile: Elles M Screever
Förderung
- National Institute of Health
- national institutes of health
Zitieren
APA
Screever, E. M., Meijers, W. C., & Moslehi, J. J. (2021). Age-Related Considerations in Cardio-Oncology. Journal of Cardiovascular Pharmacology and Therapeutics, 26(2), 103-113. https://doi.org/10.1177/1074248420968689
Vancouver
Screever EM, Meijers WC, Moslehi JJ. Age-Related Considerations in Cardio-Oncology. Journal of Cardiovascular Pharmacology and Therapeutics. 2021;26(2):103-113. doi:10.1177/1074248420968689
BibTeX
@article{Screever2021,
author = {Screever, Elles M and Meijers, Wouter C and Moslehi, Javid J},
title = {Age-Related Considerations in Cardio-Oncology},
journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
year = {2021},
volume = {26},
number = {2},
pages = {103--113},
doi = {10.1177/1074248420968689}
}
EUVIMED